October 13, 2008 - A nationally recognized faculty will present the very latest treatment strategies for patients with breast cancer in the multimedia course “Optimizing Adjuvant Breast Cancer Strategies: From Biomarkers to Treatment Selection” during National Breast Cancer Awareness Month.
This accredited course offers concise, expert reporting on key, practical treatment innovations, including research from recent American Society of Clinical Oncology (ASCO) annual meetings and San Antonio Breast Cancer Symposia. Highlights of the meeting include:
- Program Chair Antonio C. Wolff, MD, FACP, of the Johns Hopkins Sidney Kimmel Comprehensive Cancer Center, will discuss biomarkers
- Harold J. Burstein, M.D., Ph.D., from the Breast Oncology Center, the Dana-Farber Cancer Institute, and Harvard Medical School, will present on recent developments in chemotherapy-biologic treatments.
- Ana Maria Gonzalez-Angulo, M.D., MSc, of The University of Texas M. D. Anderson Cancer Center, will discuss the issue anthracycline related cardiotoxicity
Physicians can register for and take this accredited, virtual e-conference course at any time beginning Tuesday, Oct. 14, 2008, at www.virtualbreastcancer.com. Participants learn at their own pace and utilize interactive case studies, choosing treatments for simulated patients and receiving feedback on their decisions.
The faculty will offer a “Live Question-and-Answer Session” on Oct. 14, 2008, from 12:00-2:00 p.m. (EDT). The course, including faculty presentations and questions and answers generated on Oct. 14, will remain available for one year.
The course is presented by The Johns Hopkins University School of Medicine in cooperation with PharmacoMedia LLC, and is supported by an educational grant from sanofi-aventis U.S. It is available at no cost to participants.
For more information: www.virtualbreastcancer.com